Treatment of Hypothyroidism And Goiters Using Eltroxin Tablets (Levothyroxine Sodium)
Treatment with
Eltroxin Tablets is generally recommended replacement or as a supplemental therapy in patients of any age or state (including pregnancy) with hypothyroidism of any etiology except transient hypothyroidism. Eltroxin is also used as a pituitary TSH suppressant in the treatment or prevention of various types of euthyroid goiters.
The active ingredient present in Eltroxin Tablets is Levothyroxine Sodium.
Recommended Dosage - Eltroxin Tablets
The recommended initial dosage for adult patients is 50 to 100 micrograms daily and adjusted at four or six week intervals by 50 micrograms until attainment of clinical and biochemical euthyroidism. This may require doses of 100 to 200 micrograms daily. With patients over 50 years of age, it is not advisable to exceed 50 micrograms a day initially.
Side Effects Of Eltroxin Tablets
The possible side effects are fatigue, increased appetite, weight loss, heat intolerance, fever, and excessive sweating; palpitations, tachycardia, arrhythmias, increased pulse and blood pressure, heart failure, angina, myocardial infarction and cardiac arrest; headache, hyperactivity, nervousness, anxiety, irritability, emotional lability, and insomnia; hair loss, flushing; decreased bone mineral density; diarrhea, vomiting, abdominal cramps, and elevations in liver function tests; tremors, muscle weakness; menstrual irregularities, impaired fertility; and dyspnea.
Contraindications Of Eltroxin Tablets
Eltroxin Tablets are contraindicated in:
Patients with an apparent hypersensitivity to levothyroxine sodium or thyroid hormones or any of the inactive product constituents.
Patients with untreated subclinical (suppressed serum TSH with normal T3 and T4 levels) or overt thyrotoxicosis of any etiology.
Patients with acute myocardial infarction.
Patients with uncorrected adrenal insufficiency, as thyroid hormones increase tissue demands for adrenocortical hormones and may thereby precipitate acute adrenal crisis
Additional Side Effects With New Formulation Of Eltroxin Tablets
According to
http://thyroidgossip.11.forumer.com/viewtopic.php?t=79
"Eltroxin: this information page is produced by Glaxo Smith Kline and until July/August 2007 the old GSK formulation has agreed with most people. In July/August 2007 GSK decided to change the mixing compound. We as patients were not informed so therefore took months to realise that ourill health and multiple symptoms were from the medicine we were taking which up until the change in formulation had which we had taken for a long period of time with no problems. People are only realising the symptoms they have are the ones mentioned below and are associating it with their thyroxine medicine."
The old GSK formulation is given in detail in
Eltroxin Tablets by GSK Using Old Formulation
This presentation describes the use Of Eltroxin Tablets (old formulation) to treat patients of any age or state (including pregnancy) that have hypothyroidism or goiters.
